Log in or Sign up for Free to view tailored content for your specialty!
Mood Disorders News
Brain structure differs between child, adolescent conduct disorder
Recent findings provide novel evidence of quantitative differences in structural brain organization between childhood-onset and adolescence-onset conduct disorder.
Primary care intervention does not improve sepsis survivors' mental health QOL
A primary care-focused intervention program appeared to have no effect on the mental well-being of sepsis survivors, according to a recently published investigation.
Log in or Sign up for Free to view tailored content for your specialty!
Adjunctive antidepressants safe, effective for depression in schizophrenia
Recent findings indicated antidepressants added to antipsychotics for schizophrenia had small, beneficial effects with low risk for exacerbation of psychosis and adverse effects.
Adjunctive basimglurant may improve depressive symptoms in MDD
Adjunctive basimglurant modified-release was not superior to placebo regarding clinician-rated changes in depressive symptoms; however, it did show an antidepressant effect in patient-rated measures.
Risk for myocardial infarction higher among antipsychotic users
Recent findings indicated individuals who used antipsychotics had a higher risk for myocardial infarction compared with those who did not use antipsychotics. This risk was particularly high among users with schizophrenia or short-term use.
Whole-body hyperthermia effective for depressive symptoms in MDD
Whole-body hyperthermia had antidepressant effects among adults with major depressive disorder, according to recent findings.
Psilocybin may be safe, effective for treatment-resistant depression
Psilocybin may be safe and effective for treatment-resistant depression, according to recent findings.
Analysis suggests risk-based gun removal laws to reduce violence, suicide
A significant proportion of individuals with serious mental illness who committed suicide by firearms were legally eligible to purchase and possess guns, according to recent findings.
VIDEO: Treatment approaches for co-occurring substance use, psychiatric disorders
ATLANTA — In this video, Edward Nunes, MD, a professor of psychiatry at Columbia University Medical Center and New York Presbyterian Hospital, provides a number of treatment approaches for co-occurring substance use and psychiatric disorders.
Latuda safe, well-tolerated for bipolar depression
Results from an extension study indicated Latuda was safe and well-tolerated with minimal effects on weight or metabolic measures among individuals with bipolar depression.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read